Involvement of type 4 cAMP-phosphodiesterase in the myogenic differentiation of L6 cells

Molecular Biology of the Cell

Volumn 10, Issue 12, 1999, Pages 4355-4367

  Naro, Fabio ^a   Sette, Claudio ^b   Vicini, Elena ^a   De Arcangelis, Vania ^a   Grange, Muriel ^c   Conti, Marco ^d   Lagarde, Michel ^c   Molinaro, Mario ^a   Adamo, Sergio ^a   Némoz, Georges ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITÉ DE LYON   (France)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MYOGENIN; PHOSPHODIESTERASE IV; RIBONUCLEASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOPRECIPITATION; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0032714693     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.10.12.4355     Document Type: Article

References (52)

1. Alvarez, R., Sette, C., Yang, D., Eglen, R.M., Wilhelm, R., Shelton, E.R., and Conti, M. (1995). Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE4D-3. Mol. Pharmacol. 48, 616-622.
2. Bader, D., Masaki, T., and Fischman D.A. (1982). Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95, 763-770.
3. Beavo, J.A. (1995). Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 75, 725-748.
4. Bolger, G.B., Erdogan, S., Jones, R.E., Loughney, K., Scotland, G., Hoffmann, R., Wilkinson, I., Farrell, C., and Houslay, M.D. (1997). Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene. Biochem. J. 328, 539-548.
5. Bolger, G.B., Michaeli, T., Martins T., St. John, T., Steiner, B., Rodgers, L., Riggs, M., Wigler, M., and Ferguson, K. (1993). A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melagonaster are potential targets for antidepressant drugs. Mol. Cell. Biol. 13, 6558-6571.
6. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
7. Brasier, A.R., Tate, J.E., and Habener, J.F. (1989). Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques 7, 1116-1122.
8. Braun, T., Bober, E., Buschhausen-Denker, G., Kothz, S., Grzeschik, K.H., and Arnold, H.H. (1989). Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products. EMBO J. 8, 3617-3625.
9. Clegg, C.H., Linkhart, T.A., Olwin, B.B., and Hauschka, S.D. (1987). Growth factor control of skeletal muscle differentiation: committment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J. Cell Biol. 105, 949-956.
10. Colicelli, J., Birchmeier, C., Michaeli, T., O'Neill, K., Riggs, M., and Wigler, M. (1989). Isolation and characterization of a mammalian gene encoding a high-affinity cAMP phosphodiesterase. Proc. Natl. Acad. Sci. USA 86, 3599-3603.
11. Conti, M., Némoz, G., Sette, C., and Vicini, E. (1995). Recent progress in understanding the hormonal regulation of phosphodiesterases. Endocr. Rev. 16, 370-389.
12. Cossu, G., Tajbakhsh, S., and Buckingham, M. (1996). How is myogenesis initiated in the embryo? Trends Genet. 12, 218-223.
13. Cusella De Angelis, M.G., et al. (1992). MyoD, myogenin independent differentiation of primordial myoblasts in mouse somites. J. Cell Biol. 116, 1243-1255.
14. + gene. Proc. Natl. Acad. Sci. USA 86, 3604-3608.
15. Edmondson, D.G., Cheng, T.C., Cserjesi, P., Chakraborty, T., and Olson, E.N. (1992). Analysis of the myogenin promoter reveals an indirect pathway for positive autoregulation mediated by the muscle-specific enhancer factor MEF-2. Mol. Cell. Biol. 12, 3665-3677.
16. Engert, J.C., Berglund, E.B., and Rosenthal, N. (1996). Proliferation precedes differentiation in IGF-I stimulated myogenesis. J. Cell Biol. 135, 431-440.
17. Florini, J.R. (1987). Hormonal control of muscle growth. Muscle Nerve 10, 577-598.
18. Florini, J.R., Ewton, D.Z., and Magri, K.A. (1991). Hormones, growth factors, and myogenic differentiation. Annu. Rev. Physiol. 53, 201-216.
19. Grange, M., Picq, M., Prigent, A.F., Lagarde, M., and Némoz, G. (1998). Regulation of PDE-4 cAMP phosphodiesterases by phosphatidic acid. Cell Biochem. Biophys. 29, 1-17.
20. Houslay, M.D., Sullivan, M., and Bolger, G.B. (1998). The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: intracellular targeting, regulation, and selective inhibition by compounds exerting ant-inflammatory and antidepressant actions. Adv. Pharmacol. 44, 225-342.
21. Hu, J.S., and Olson, E.N. (1988). Regulation of differentiation of the BC3H1 muscle cell line through cAMP-dependent and -independent pathways. J. Biol. Chem. 263, 19670-19677.
22. Huston, E., Pooley, L., Julien, P., Scotland, G., McPhee, I., Sullivan, M., Bolger, G.B., and Houslay, M.D. (1996). The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B) expressed in transfected COS7 cells occurs as both particulate and cytosolic species that exhibit distinct kinetics of inhibition by the antidepressant rolipram. J. Biol. Chem. 271, 31334-31344.
23. Iona, S., Cuomo, M., Bushnik, T., Naro, F., Sette, C., Hess, M., Shelton, E.R., and Conti, M. (1998). Characterization of the rolipram-sensitive, cAMP specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain. Mol. Pharmacol. 53, 23-32.
24. Jin, S.L.C., Bushnik, T., Lan, L., and Conti, M. (1998). Subcellular localization of rolipram-sensitive, cAMP-specific phosphodiesterases. J. Biol. Chem. 273, 19672-19678.
25. Kovala, T., Lorimer, I.A.J., Brickenden, A.M., Ball, E.H., and Sanwal, B.D. (1994). Protein kinase A regulation of cAMP phosphodiesterase expression in rat skeletal myoblasts. J. Biol. Chem. 269, 8680-8685.
26. Li, L., Heller-Harrison, R., Czech, M., and Olson, E.N. (1992). Cyclic AMP-dependent protein kinase activity inhibits the activity of myogenic helix-loop-helix proteins. Mol. Cell. Biol. 12, 4478-4485.
27. Ludolph, D.C., and Konieczny, S.F. (1995). Transcription factor families: muscling in on the myogenic program. FASEB J. 9, 1595-1604.
28. Minotti, S., Scicchitano, B.M., Nervi, C., Scarpa, S., Lucarelli, M., Molinaro, M., and Adamo, S. (1998). Vasopressin and insulin-like growth factors synergistically induce myogenesis in serum-free medium. Cell Growth & Differ. 9, 155-163.
29. Nadal-Ginard, B. (1978). Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. Cell 15, 855-864.
30. Naro, F., Donchenko, V., Minotti, S., Zolla, L., Molinaro, M., and Adamo, S. (1997). Role of phospholipase C and D signaling pathways in vasopressin-dependent myogenic differentiation. J. Cell. Physiol. 171, 34-42.
31. Naro, F., Fazzini, A., Citro, G., Malatesta, F., Antonini, G., Sarti, P., Brunori, M., Franconi, F., and Giotti, A. (1991). Immunoquantitation of cytochrome c in cardiac perfusate. J. Immunoassay 12, 251-262.
32. Naro, F., Zhang, R., and Conti, M. (1996). Developmental regulation of unique cyclic adenosine 3′-5′-monophosphate-specific phosphodiesterase variants during rat spermatogenesis. Endocrinology 137, 2464-2472.
33. Némoz, G., Sette, C., and Conti, M. (1997). Selective activation of rolipram-sensitive, cAMP-specific phosphodiesterase isoforms by phosphatidic acid. Mol. Pharmacol. 51, 242-249.
34. Nervi, C., Benedetti, L., Minasi, A., Molinaro, M., and Adamo, S. (1995). Arginine-vasopressin induces differentiation of skeletal myogenic cells and up-regulation of myogenin and myf-5. Cell Growth & Differ. 6, 81-89.
35. Olson, E.N., Sternberg, E., Hu, J.S., Spizz, G., and Wilcox, C. (1986). Regulation of myogenic differentiation by type β transforming growth factor. J. Cell Biol. 103, 1799-1805.
36. O'Neill, M.C., and Stockdale, F.E. (1972). A kinetic analysis of myogenesis in vitro. J. Cell Biol. 52, 52-65.
37. Salminen, A., Braun, T., Buchberger, A., Jurs, S., Winter, B., and Arnold, H.H. (1991). Transcription of the muscle regulatory gene MYF4 is regulated by serum components, peptide growth factors and signaling pathways involving G proteins. J. Cell Biol. 115, 905-917.
38. Schwabe, U., Miyake, M., Ohga, Y., and Daly, J.W. (1976). 4-(-3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3′ 5′-mono-phosphate-phosphodiesterases in homogenates and tissue slices from rat brain. Mol. Pharmacol. 12, 900-910.
39. Sette, C., and Conti, M. (1996). Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation. J. Biol. Chem. 271, 16526-16534.
40. Sette, C., Iona, S., and Conti, M. (1994a). The short-term activation of a rolipram-sensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP dependent phosphorylation. J. Biol. Chem. 269, 9245-9252.
41. Sette, C., Vicini, E., and Conti, M. (1994b). Modulation of cellular responses by hormones: role of cAMP specific, rolipram sensitive phosphodieserases. Mol. Cell. Endocrinol. 100, 75-79.
42. Sette, C., Vicini, E., and Conti, M. (1994c). The ratPDE3/IVd phosphodiesterase gene codes for multiple proteins differentially activated by cAMP-protein kinase. J. Biol. Chem. 269, 18271-18274.
43. Soderling, S.H., Bayuga, S.J., and Beavo, J.A. (1998). Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase. Proc. Natl. Acad. Sci. USA 95, 8991-8996.
44. Souness, J.E., and Rao, S. (1997). Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases. Cell. Signalling 9, 227-236.
45. Swinnen, J.V., Joseph, D.R., and Conti, M. (1989). Molecular cloning of rat homologues of the Drosophila melanogaster dunce cAMP phosphodiesterase: evidence for a family of genes. Proc. Natl. Acad. Sci. USA 86, 5325-5329.
46. Teti, A., Naro, F., Molinaro, M., and Adamo, S. (1993). Transduction of the arginine-vasopressin signal in skeletal myogenic cells. Am. J. Physiol. 265, C113-C121.
47. Thompson, W.J., Brooker, G., and Appleman, M.M. (1974). Assay of cyclic nucleotide phosphodiesterase with radioactive substrates. Methods Enzymol. 38, 205-212.
48. Vicini, E., and Conti, M. (1997). Characterization of an intronic promoter of a cyclic adenosine 3′,5′-monophosphate (cAMP)-specific phosphodiesterase gene that confers hormone and cAMP inducibility. Mol. Endocrinol. 11, 839-850.
49. Wahrman, J.P., Winand, R., and Luzzatti, D. (1973). Effect of cyclic AMP on growth and morphological differentiation of an established myogenic cell line. Nature 245, 112-113.
50. Wakelam, M.J.O., Patterson, S., and Hanley, M.R. (1987). L6 skeletal muscle cells have functional V1 vasopressin receptors coupled to stimulated inositol phospholipid metabolism. FEBS Lett. 210, 181-184.
51. Winter, B., Braun, T., and Arnold, H.H. (1993). cAMP-dependent protein kinase represses myogenic differentiation and the activity of the muscle-specific helix-loop-helix transcription factors Myf-5 and MyoD. J. Biol. Chem. 268, 9869-9878.
52. Yaffe, D. (1968). Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc. Natl. Acad. Sci. USA 61, 477-483.